235 related articles for article (PubMed ID: 23851505)
1. GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation.
Shan L; Li X; Liu L; Ding X; Wang Q; Zheng Y; Duan Y; Xuan C; Wang Y; Yang F; Shang Y; Shi L
Oncogene; 2014 Jun; 33(24):3205-16. PubMed ID: 23851505
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth.
Izzo F; Mercogliano F; Venturutti L; Tkach M; Inurrigarro G; Schillaci R; Cerchietti L; Elizalde PV; Proietti CJ
Breast Cancer Res; 2014 Dec; 16(6):491. PubMed ID: 25479686
[TBL] [Abstract][Full Text] [Related]
3. The role of p38 signaling and poly(ADP-ribosyl)ation-induced metabolic collapse in the osteogenic differentiation-coupled cell death pathway.
Robaszkiewicz A; Valkó Z; Kovács K; Hegedűs C; Bakondi E; Bai P; Virág L
Free Radic Biol Med; 2014 Nov; 76():69-79. PubMed ID: 25078118
[TBL] [Abstract][Full Text] [Related]
4. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
Hsiang CH; Straus DS
Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1-dependent gene expression.
Elser M; Borsig L; Hassa PO; Erener S; Messner S; Valovka T; Keller S; Gassmann M; Hottiger MO
Mol Cancer Res; 2008 Feb; 6(2):282-90. PubMed ID: 18314489
[TBL] [Abstract][Full Text] [Related]
6. LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1.
Ai B; Kong X; Wang X; Zhang K; Yang X; Zhai J; Gao R; Qi Y; Wang J; Wang Z; Fang Y
Cell Death Dis; 2019 Jun; 10(7):502. PubMed ID: 31243265
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin resistance associated with PARP hyperactivation.
Michels J; Vitale I; Galluzzi L; Adam J; Olaussen KA; Kepp O; Senovilla L; Talhaoui I; Guegan J; Enot DP; Talbot M; Robin A; Girard P; Oréar C; Lissa D; Sukkurwala AQ; Garcia P; Behnam-Motlagh P; Kohno K; Wu GS; Brenner C; Dessen P; Saparbaev M; Soria JC; Castedo M; Kroemer G
Cancer Res; 2013 Apr; 73(7):2271-80. PubMed ID: 23554447
[TBL] [Abstract][Full Text] [Related]
8. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
[TBL] [Abstract][Full Text] [Related]
9. Methylation of Gata3 protein at Arg-261 regulates transactivation of the Il5 gene in T helper 2 cells.
Hosokawa H; Kato M; Tohyama H; Tamaki Y; Endo Y; Kimura MY; Tumes DJ; Motohashi S; Matsumoto M; Nakayama KI; Tanaka T; Nakayama T
J Biol Chem; 2015 May; 290(21):13095-103. PubMed ID: 25861992
[TBL] [Abstract][Full Text] [Related]
10. PARP1 Val762Ala polymorphism reduces enzymatic activity.
Wang XG; Wang ZQ; Tong WM; Shen Y
Biochem Biophys Res Commun; 2007 Mar; 354(1):122-6. PubMed ID: 17214964
[TBL] [Abstract][Full Text] [Related]
11. HOXC8 promotes breast tumorigenesis by transcriptionally facilitating cadherin-11 expression.
Li Y; Chao F; Huang B; Liu D; Kim J; Huang S
Oncotarget; 2014 May; 5(9):2596-607. PubMed ID: 24810778
[TBL] [Abstract][Full Text] [Related]
12. The histone methyltransferase SMYD2 methylates PARP1 and promotes poly(ADP-ribosyl)ation activity in cancer cells.
Piao L; Kang D; Suzuki T; Masuda A; Dohmae N; Nakamura Y; Hamamoto R
Neoplasia; 2014 Mar; 16(3):257-64, 264.e2. PubMed ID: 24726141
[TBL] [Abstract][Full Text] [Related]
13. Lycopene metabolite, apo-10'-lycopenoic acid, inhibits diethylnitrosamine-initiated, high fat diet-promoted hepatic inflammation and tumorigenesis in mice.
Ip BC; Hu KQ; Liu C; Smith DE; Obin MS; Ausman LM; Wang XD
Cancer Prev Res (Phila); 2013 Dec; 6(12):1304-16. PubMed ID: 24085778
[TBL] [Abstract][Full Text] [Related]
14. BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency.
Shen Y; Rehman FL; Feng Y; Boshuizen J; Bajrami I; Elliott R; Wang B; Lord CJ; Post LE; Ashworth A
Clin Cancer Res; 2013 Sep; 19(18):5003-15. PubMed ID: 23881923
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.
Brenner JC; Ateeq B; Li Y; Yocum AK; Cao Q; Asangani IA; Patel S; Wang X; Liang H; Yu J; Palanisamy N; Siddiqui J; Yan W; Cao X; Mehra R; Sabolch A; Basrur V; Lonigro RJ; Yang J; Tomlins SA; Maher CA; Elenitoba-Johnson KS; Hussain M; Navone NM; Pienta KJ; Varambally S; Feng FY; Chinnaiyan AM
Cancer Cell; 2011 May; 19(5):664-78. PubMed ID: 21575865
[TBL] [Abstract][Full Text] [Related]
16. Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.
French JD; Ghoussaini M; Edwards SL; Meyer KB; Michailidou K; Ahmed S; Khan S; Maranian MJ; O'Reilly M; Hillman KM; Betts JA; Carroll T; Bailey PJ; Dicks E; Beesley J; Tyrer J; Maia AT; Beck A; Knoblauch NW; Chen C; Kraft P; Barnes D; González-Neira A; Alonso MR; Herrero D; Tessier DC; Vincent D; Bacot F; Luccarini C; Baynes C; Conroy D; Dennis J; Bolla MK; Wang Q; Hopper JL; Southey MC; Schmidt MK; Broeks A; Verhoef S; Cornelissen S; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Fasching PA; Loehberg CR; Ekici AB; Beckmann MW; Peto J; dos Santos Silva I; Johnson N; Aitken Z; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Truong T; Laurent-Puig P; Menegaux F; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Milne RL; Zamora MP; Arias Perez JI; Benitez J; Anton-Culver H; Brenner H; Müller H; Arndt V; Stegmaier C; Meindl A; Lichtner P; Schmutzler RK; Engel C; Brauch H; Hamann U; Justenhoven C; ; Aaltonen K; Heikkilä P; Aittomäki K; Blomqvist C; Matsuo K; Ito H; Iwata H; Sueta A; Bogdanova NV; Antonenkova NN; Dörk T; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; ; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Lambrechts D; Peeters S; Smeets A; Floris G; Chang-Claude J; Rudolph A; Nickels S; Flesch-Janys D; Radice P; Peterlongo P; Bonanni B; Sardella D; Couch FJ; Wang X; Pankratz VS; Lee A; Giles GG; Severi G; Baglietto L; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Teo SH; Yip CH; Ng CH; Vithana EN; Kristensen V; Zheng W; Deming-Halverson S; Shrubsole M; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Devilee P; Seynaeve C; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Czene K; Klevebring D; Schoof N; Hooning MJ; Martens JW; Collée JM; Tilanus-Linthorst M; Hall P; Li J; Liu J; Humphreys K; Shu XO; Lu W; Gao YT; Cai H; Cox A; Balasubramanian SP; Blot W; Signorello LB; Cai Q; Pharoah PD; Healey CS; Shah M; Pooley KA; Kang D; Yoo KY; Noh DY; Hartman M; Miao H; Sng JH; Sim X; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Sangrajrang S; Gaborieau V; McKay J; Toland AE; Ambrosone CB; Yannoukakos D; Godwin AK; Shen CY; Hsiung CN; Wu PE; Chen ST; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; Ponder BA; Nevanlinna H; Brown MA; Chenevix-Trench G; Easton DF; Dunning AM
Am J Hum Genet; 2013 Apr; 92(4):489-503. PubMed ID: 23540573
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanisms of regulaion of transcription by PARP1].
Maliuchenko NV; Kulaeva OI; Kotova E; Chupyrkina AA; Nikitin DV; Kirpichnikov MP; Studitskiĭ VM
Mol Biol (Mosk); 2015; 49(1):99-113. PubMed ID: 25916114
[TBL] [Abstract][Full Text] [Related]
18. PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma.
Majuelos-Melguizo J; Rodríguez MI; López-Jiménez L; Rodríguez-Vargas JM; Martí Martín-Consuegra JM; Serrano-Sáenz S; Gavard J; de Almodóvar JM; Oliver FJ
Oncotarget; 2015 Mar; 6(7):4790-803. PubMed ID: 25576921
[TBL] [Abstract][Full Text] [Related]
19. Necdin is a breast cancer metastasis suppressor that regulates the transcription of c-Myc.
Lee M; Beggs SM; Gildea D; Bupp S; Lichtenberg J; Trivedi NS; ; Hu Y; Bodine DM; Crawford NP
Oncotarget; 2015 Oct; 6(31):31557-68. PubMed ID: 26384308
[TBL] [Abstract][Full Text] [Related]
20. The level of Ets-1 protein is regulated by poly(ADP-ribose) polymerase-1 (PARP-1) in cancer cells to prevent DNA damage.
Legrand AJ; Choul-Li S; Spriet C; Idziorek T; Vicogne D; Drobecq H; Dantzer F; Villeret V; Aumercier M
PLoS One; 2013; 8(2):e55883. PubMed ID: 23405229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
